Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
Effectiveness Without Efficacy: Cautionary Tale from a Landmark Breast Cancer Randomized Controlled Trial, Yu Shen, Jing Ning, Heather Y Lin, et al.
Angiotensin II Type 2 Receptor Signalling as a Pain Target: Bench, Bedside and Back-Translation, Andrew J Shepherd, Andrew Sc Rice, and Maree T Smith
Prevalence and Implications of Significance Testing for Baseline Covariate Imbalance in Randomised Cancer Clinical Trials: The Table 1 Fallacy, Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
VIP152 Is a Selective CDK9 Inhibitor With Pre-clinical In Vitro and In Vivo Efficacy in Chronic Lymphocytic Leukemia, Steven Sher, Ethan Whipp, Janek Walker, et al.
Machine Learning and Acute Stroke Imaging, Sunil A Sheth, Luca Giancardo, Marco Colasurdo, et al.
High Throughput Single Cell Long-Read Sequencing Analyses of Same-Cell Genotypes and Phenotypes in Human Tumors, Cheng-Kai Shiau, Lina Lu, Rachel Kieser, et al.
Transcriptome-Wide Profiling of Acute Stress Induced Changes in Ribosome Occupancy Level Using External Standards, Annie W Shieh, Sandeep K Bansal, Zhen Zuo, et al.
Genome-Wide Association Study of Lung Adenocarcinoma In East Asia and Comparison With A European Population, Jianxin Shi, Kouya Shiraishi, Jiyeon Choi, et al.
Financial Toxicity in Cancer Patients and Subsequent Risk of Repeat Acute Care Utilization, Julia J Shi, J Alberto Maldonado, Chi-Fang Wu, et al.
Financial Toxicity in Cancer Patients and Subsequent Risk of Repeat Acute Care Utilization, Julia J Shi, J Alberto Maldonado, Chi-Fang Wu, et al.
Pilot Study of a Spanish Language Measure of Financial Toxicity in Underserved Hispanic Cancer Patients With Low English Proficiency, Julia J Shi, Gwendolyn J McGinnis, Susan K Peterson, et al.
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01, Toshio Shimizu, Jacob Sands, Kiyotaka Yoh, et al.
A Cross-Sectional Study to Test Equivalence of Low- Versus Intermediate-Flip Angle Dynamic Susceptibility Contrast MRI Measures of Relative Cerebral Blood Volume in Patients With High-Grade Gliomas at 15 Tesla Field Strength, Mark S Shiroishi, Dane Weinert, Steven Y Cen, et al.
The Non-Coding RNA Journal Club: Highlights on Recent Papers—12, Patrick K T Shiu, Mirolyuba Ilieva, Anja Holm, et al.
Immune Checkpoint B7-H3 Is a Therapeutic Vulnerability in Prostate Cancer Harboring Pten and TP53 Deficiencies, Wei Shi, Yin Wang, Yuehui Zhao, et al.
TP53 Gain-of-Function Mutation Modulates the Immunosuppressive Microenvironment in Non-HPV-Associated Oral Squamous Cell Carcinoma, Yewen Shi, Xiaoyong Ren, Shaolong Cao, et al.
PRMT3-Mediated Arginine Methylation of IGF2BP1 Promotes Oxaliplatin Resistance in Liver Cancer, Yunxing Shi, Yi Niu, Yichuan Yuan, et al.
Sparse Tree-Based Clustering of Microbiome Data to Characterize Microbiome Heterogeneity in Pancreatic Cancer, Yushu Shi, Liangliang Zhang, Kim-Anh Do, et al.
Circulating Long Non-Coding RNAs As Novel Diagnostic Biomarkers for Alzheimer’s Disease (Ad): A Systematic Review and Meta-Analysis, Parnian Shobeiri, Sanam Alilou, Mehran Jaberinezhad, et al.
Peripheral Levels of the Brain-Derived Neurotrophic Factor in Coronary Artery Disease: A Systematic Review and Meta-Analysis, Parnian Shobeiri, Amir Hossein Behnoush, Amirmohammad Khalaji, et al.
Bayesian Feature Selection for Radiomics Using Reliability Metrics, Katherine Shoemaker, Rachel Ger, Laurence E Court, et al.
Protective Role of Colitis in Inflammatory Arthritis via Propionate-Producing Bacteroides in the Gut, Hoh-Jeong Shon, Yu-Mi Kim, Kyeong Seog Kim, et al.
Ultrasensitive Ngs Mrd Assessment in Ph+ All: Prognostic Impact and Correlation With Rt-Pcr for BCR::ABL1, Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
A Phase 1/2 Study of Azacitidine, Venetoclax and Pevonedistat in Newly Diagnosed Secondary AML and in MDS or CMML After Failure of Hypomethylating Agents, Nicholas J Short, Muharrem Muftuoglu, Faustine Ong, et al.
A Phase 1/2 Study of Azacitidine, Venetoclax and Pevonedistat in Newly Diagnosed Secondary AML and in MDS or CMMLAfter Failure of Hypomethylating Agents, Nicholas J Short, Muharrem Muftuoglu, Faustine Ong, et al.